Paul L Kimmel Selected Research

Type II Tumor Necrosis Factor Receptors

1/2022	Longitudinal TNFR1 and TNFR2 and Kidney Outcomes: Results from AASK and VA NEPHRON-D.
1/2022	Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul L Kimmel Research Topics

Disease

54	Chronic Kidney Failure (Chronic Renal Failure) 12/2023 - 06/2002
35	Chronic Renal Insufficiency 05/2024 - 10/2002
23	Kidney Diseases (Kidney Disease) 04/2024 - 05/2000
20	Inflammation (Inflammations) 01/2023 - 12/2003
15	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 01/2007
10	Atherosclerosis 05/2024 - 07/2006
10	Renal Insufficiency (Renal Failure) 04/2024 - 12/2003
10	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2005
9	Heart Failure 05/2024 - 03/2014
8	Hypertension (High Blood Pressure) 01/2023 - 09/2003
8	HIV Infections (HIV Infection) 05/2016 - 02/2003
7	Pain (Aches) 12/2023 - 07/2004
7	Infections 11/2022 - 02/2003
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 03/2014
6	Albuminuria 01/2023 - 01/2016
6	Fibrosis (Cirrhosis) 01/2023 - 01/2021
6	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 10/2019 - 05/2000
5	Diabetes Mellitus 01/2023 - 02/2012
4	Myocardial Infarction 01/2023 - 10/2005
4	Stroke (Strokes) 07/2022 - 10/2005
4	Glomerulonephritis 01/2010 - 05/2000
3	Proteinuria 05/2024 - 01/2019
3	Chronic Pain 12/2023 - 01/2018
3	Atrophy 12/2023 - 01/2021
3	Sepsis (Septicemia) 01/2023 - 01/2007
3	Disease Progression 07/2022 - 01/2017
3	Hypotension (Low Blood Pressure) 01/2019 - 01/2007
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2018 - 04/2015
3	Mental Disorders (Mental Disorder) 11/2008 - 01/2007
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2007 - 05/2003
2	Reperfusion Injury 12/2023 - 01/2023
2	Pneumonia (Pneumonitis) 01/2023 - 04/2017
2	Obesity 01/2018 - 02/2004
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 07/2015
2	Chronic Disease (Chronic Diseases) 05/2016 - 02/2003
2	Critical Illness (Critically Ill) 09/2013 - 03/2008
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2010 - 07/2006
2	Anemia 11/2007 - 01/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 07/2006 - 08/2003
2	Cysts 12/2003 - 09/2003
2	Autosomal Dominant Polycystic Kidney (ADPKD) 12/2003 - 09/2003
2	Thrombotic Microangiopathies 05/2003 - 05/2000
1	Heart Diseases (Heart Disease) 01/2023
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2023
1	Cytopenia 11/2022
1	Azotemia 10/2022

Drug/Important Bio-Agent (IBA)

34	Biomarkers (Surrogate Marker)IBA 05/2024 - 02/2003
24	CreatinineIBA 01/2023 - 09/2003
15	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2003
13	AlbuminsIBA 10/2018 - 09/2003
6	Antigen-Antibody Complex (Immune Complex)IBA 05/2016 - 05/2000
5	Opioid Analgesics (Opioids)IBA 12/2023 - 12/2017
4	CytokinesIBA 11/2022 - 02/2003
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2022 - 04/2015
4	Apolipoprotein L1IBA 03/2020 - 11/2011
4	Serum AlbuminIBA 01/2019 - 11/2005
4	Interleukin-6 (Interleukin 6)IBA 01/2016 - 02/2003
3	Epidermal Growth Factor (EGF)IBA 12/2023 - 10/2021
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2023 - 01/2020
3	Analgesics (Analgesic Drugs)IBA 01/2022 - 05/2006
3	C-Reactive ProteinIBA 01/2019 - 10/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 02/2003
3	MineralsIBA 10/2016 - 01/2015
3	Interleukin-1 (Interleukin 1)IBA 01/2016 - 02/2003
2	trimethyloxamine (trimethylamine N-oxide)IBA 11/2023 - 10/2022
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2023 - 07/2022
2	UromodulinIBA 01/2023 - 07/2022
2	Lipocalin-2IBA 01/2023 - 01/2017
2	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022 - 01/2022
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022 - 01/2022
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2020 - 10/2019
2	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 01/2005
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019 - 01/2016
2	Fibrinogen (Factor I)FDA Link 01/2019 - 01/2016
2	Cystatin CIBA 10/2017 - 01/2017
2	Vitamin D FDA LinkGeneric 02/2016 - 05/2012
2	ElectrolytesIBA 11/2015 - 09/2003
2	SteroidsIBA 11/2011 - 11/2007
2	Tacrolimus (Prograf)FDA LinkGeneric 04/2011 - 11/2005
2	AntibodiesIBA 11/2008 - 02/2003
2	CholesterolIBA 01/2007 - 10/2005
2	ChemokinesIBA 08/2003 - 02/2003
2	Chemokine ReceptorsIBA 02/2003 - 05/2000
1	ProteomeIBA 04/2024
1	Blood Proteins (Serum Proteins)IBA 10/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2022
1	PseudouridineIBA 10/2022
1	homocitrullineIBA 10/2022
1	symmetric dimethylarginineIBA 10/2022

Therapy/Procedure

31	Renal Dialysis (Hemodialysis) 12/2023 - 06/2002
15	Therapeutics 05/2024 - 08/2002
8	Kidney Transplantation 01/2022 - 06/2004
7	Transplantation 01/2022 - 03/2005
5	Highly Active Antiretroviral Therapy (HAART) 05/2016 - 08/2003
4	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 07/2006
3	Peritoneal Dialysis 03/2005 - 10/2002
2	Pain Management 01/2022 - 01/2021
1	Patient Readmission 01/2023